InvestorsHub Logo

Amatuer17

06/11/18 7:56 AM

#23177 RE: Northstar42 #23175

I see this from the PR

“ The trial met the primary efficacy endpoint: the proportion of patients with ≥0.5 log10 reduction in HIV-1 RNA viral load from baseline at the end of the one-week treatment period (p?0.01).”

Where you see the number?

Inoviorulez

06/11/18 8:21 AM

#23178 RE: Northstar42 #23175

Correct 0.0032 is the best p-value , or close to the best you can get basically the gold standard. Also BLA filing is imminent, and CYDY is a buy just based on that alone.